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doi:10.1016/j.ejvs.2008.06.023Abstract Objective: The study aimed to define early clinical outcomes, and medium term
morphological changes, following endovascular treatment of acute (AAD) and chronic (CAD)
Type B aortic dissections.
Main outcomes: The cohort comprised 78 patients who underwent endovascular repair for AAD
(38) and CAD (40). Early and late clinical outcomes were prospectively recorded. All patients
underwent serial follow up with CT scanning. False lumen thrombosis rates, true, false and
total aortic short axis diameter were recorded at the mid point of the endograft and below this
level in the thoracic aorta. The total maximum aortic diameter in the thoracic, abdominal
aorta was quantified.
Results: The 30-d mortality was 2.6% in AAD and 7.5% in CAD. The 30-d stroke and paraplegia
rates were 5.3% and 0% in AAD. There were no cases of stroke or paraplegia in patients with
CAD. At 30 months follow up, the cumulative survival for the two groups was 93% for AAD
and 66.5% for CAD (PZ 0.015, Kaplan Meier) and the cumulative re-intervention rate was
62% and 55% in AAD and CAD respectively (PZ 0.961, Kaplan-Meier). False lumen thrombosis
rates were equivalent in the two groups and were higher at the level of the endograft than
below this level (P< 0.05). Aortic remodelling was greater in AAD, whereas the aortic dimen-
sions after treatment of CAD remained relatively static. Up to 20% of patients in both groups
demonstrated enlargement of the thoracic aorta.
Conclusions: The data support the use of endovascular repair of the thoracic aorta in Type B
aortic dissection. 30-d outcomes are acceptable. Patients with AAD demonstrate significant
aortic remodelling whereas patients with CAD do not. This has significant implications for prac-
tice as patients with CAD must rely on maintenance of false lumen thrombosis to preserve the
integrity of the endovascular repair.
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Aortic Morphology Following Endovascular Repair of Acute and Chronic Type B Aortic Dissection 523Introduction rupture (haemothorax, haemomediastinum), malperfusionThe management of Stanford Type B aortic dissection has
undergone fundamental change over the past decade.1
Conventional surgical intervention for acute Type B dissec-
tions was reserved for life threatening complications and
was associated with a significant mortality, even in highly
specialised centres.2 The adoption of endovascular repair
for acute Type B dissections has shown considerable
promise, and registry outcomes have suggested that early
mortality for comparable patient groups is significantly
lower than the surgical alternatives.3,4 Endovascular tech-
niques have more recently been applied to the treatment
of chronic dissections that have become complicated or
which have progressed to aneurysmal degeneration. The
results of these interventions are less well defined than
for acute lesions,5,6 and carefully reported series are
required to determine the efficacy of endovascular therapy
in the chronic phase of Type B dissection.
An important component of endovascular therapy for
aortic dissections is the long-term changes that occur in the
stented segment and distal aorta. Endovascular therapy in
the acute phase relies on covering the primary entry tear to
initiate false lumen thrombosis, expand the true lumen and
stimulate aortic remodelling. In chronic dissections,
covering the primary tear may not be sufficient to oblit-
erate flow in the false lumen and preliminary studies have
suggested that the potential for remodelling may be less.7
The aim of the present study was to document the
outcome of a large cohort of patients undergoing endovas-
cular treatment of Type B aortic dissection. In addition to
clinical outcomes, the study documented the morpholog-
ical changes in the aorta that occurred after the endovas-
cular repair.Methods
A prospective database of all patients undergoing endovas-
cular treatment for Stanford Type B aortic dissections, at
a tertiary referral centre, was maintained from Feb 2000 to
Feb 2007. The databases included clinical outcomes,
secondary procedures and details of treatment.
Stanford Type B dissections were sub-classified according
to the recommendations of the European Society of Cardi-
ology.8 Acute dissections (AAD) were defined by a period of 2
weeks from onset of symptoms and chronic dissections (CAD)
by an elapsed time of greater than 2 weeks following initial
dissection.1 The reported cohort consisted of 78 patients;
38 with acute dissections and 40 with chronic dissections.
The acute group comprised 4 patients with penetrating
thoracic ulcers (EuropeanTask Force Type4), 5with intramu-
ral haematoma (Type2), and29with classic dissections (Type
1). Patients with traumatic aortic transaction were not
considered in this investigation.
Indications for endovascular treatment
In our centre, endovascular repair is the preferred option
for the treatment of complicated Type B aortic dissection.
Indications for intervention in acute aortic syndrome were(acute limb ischaemia, intestinal ischaemia, renal
ischaemia), persistent pain for a 3 day period or hyperten-
sion refractory to treatment. In the acute patient cohort,
10 patients presented with aortic rupture, 4 had renal
ischaemia and 4 mesenteric ischaemia. Chronic dissections
were considered for intervention in the presence of compli-
cations (rupture, acute dissection, end organ ischaemia or
pain), maximum short axis thoracic aortic diameter
exceeding 5.5 cm, or rapid growth of the thoracic aorta
(1 cm in 6 months e local protocol). Four of the 40 patients
treated for CAD presented with aortic rupture and one with
visceral ischaemia. The demographics of the patient cohort
are illustrated in Table 1.
Post procedural imaging
All patients were imaged with computerised tomography
(CT) as the preferred modality. Patients were imaged
before endovascular repair; prior to discharge and then at
3 months, 6 months and yearly thereafter. The short axis
diameter of the true lumen, false lumen and total aorta
was quantified for each CT scan at 7 levels (mid aortic arch,
upper edge of the descending aorta, the carina, lower left
atrium, coeliac axis, uppermost renal artery and the iliac
bifurcation).7 The patency of true and false lumens was
determined at these levels and was also related to the level
of the endograft (i.e. false lumen patency at the mid point
of the endograft and below the endograft). The maximum
aortic diameter of the ascending, descending thoracic and
abdominal aorta was recorded.
Analysis of false lumen thrombosis, and true and false
lumen diameters did not include those patients with
penetrating ulcers or intramural haematomas as these
did not have a defined false lumen that could be
examined.
Statistical analysis
Statistical analysis was performed using SPSS 14.0 (SPSS Inc,
Chicago, IL) and Excel 2003. Continuous variables are pre-
sented as mean with 95% confidence intervals. Comparison
between continuous variables utilised the student T test.
Categorical variables were analysed by Chi squared and Fish-
er’s exact tests. Analysis of variance was utilised to compare
short axis, false lumen and true lumen diameters over the
follow up period. Cumulative survival rates were calculated
using Kaplan Meier analysis and presented as life tables.
Results
Procedural details of initial endovascular repair
Endovascular coverage of the primary entry tear was
achieved in all cases. There were a total of 57 stents
used in 38 acute cases for a mean of 1.5 endografts per case
(24 Valiant endografts [Medtronic, Santa Rosa, CA], 19
Talent grafts [Medtronic], 11 Excluder grafts [WL Gore,
Flagstaff, AZ], and 3 TX2 [Cook Medical, Limerick, Eire]). In
the patients with CAD, 2.12 endografts per patient (85
Table 1 displaying patient demographics for the cohorts with acute and chronic dissections. Risk factors are tabulated as the
percentage of patients with each SVS/ISCVS score for eight domains. Type of surgery gives the proportion of patients who have
had aortic surgery, cardiac surgery or previous endovascular intervention
Acute (nZ 38) Chronic (nZ 40) P
Age 62.5 15.1 66.6 11.9 0.19
Sex Male 26 Female 12 Male 26 Female 14
Aetiology of dissection
Atherosclerosis 17 (44.2%) 21 (52.5%) 0.5072
Hypertension 22 (57.2%) 27 (67.5%) 0.4831
Marfan 3 (7.8%) 7 (17.5%) 0.4238
Other 2 (5.2%) 0 (0%) 0.3118
0.066
SVS Score 0 1
Smoking 44.7% 5.3% 2 3 0 1 2 3
Hypertension 21% 27.5% 31.6% 18.4% 47.5% 10% 15% 27.5% 0.306
Diabetes 89.5% 0% 26.5% 25% 17.5% 2.5% 17.5% 62.5% 0.001
Hyperlipidaemia 65.8% 0% 7.9% 2.6% 90% 2.5% 2.5% 5% 0.505
Cardiac Disease 84.2% 2.6% 10.5% 23.7% 42.5% 0% 2.5% 55% 0.017
Carotid Disease 89.5% 0% 7.9% 5.3% 70% 15% 12.5% 2.5% 0.202
Renal Impairment 89.4% 5.3% 7.9% 2.6% 87.5% 0% 7.5% 5% 0.297
Pulmonary Disease 81.5% 13.2% 5.3% 0% 62.5% 25% 5% 7.5% 0.022
Overall SVS 7.9% 10.5% 5.3% 0% 85% 2.5% 12.5% 0% 0.133
23.7% 57.9% 2.5% 5% 7.5% 85% 0.066
Medications
Antiplatelet 4 (10.4%) 19 (47.5%)
Warfarin 1 (2.6%) 3 (7.5%) 0.0004
Statins 8 (20.8%) 26 (65%) 0.6156
B Blocker 11 (28.6%) 30 (75%) 0.0001
ACE Inhibitor 13 (33.8%) 20 (50%) 0.0001
A2RB 2 (5.2%) 5 (12.5%) 0.1766
Ca Channel Blocker 3 (7.8%) 22 (55%) 0.4321
Diuretic 9 (23.4%) 21 (52.5%) 0.0001
0.0111
Previous Vascular Reconstruction
Aortic Surgery 1 (2.6%) 11 (27.5%)
Cardiac Surgery 1 (2.6%) 3 (7.5%) 0.0033
Endovascular 1 (2.6%) 1 (2.5%) 0.6156
1.0000
524 D. Sayer et al.grafts) were deployed (46 Valiant, 33 Talent, and 6
Excluder). The mean distance of the aorta covered was
182 18 mm in AAD and 204 20 mm in CAD. The proximal
and distal stent diameters were 30.8 1.7 mm and 28.4
1.4 mm in acute and 32.9 1.3 mm and 26.9 2.0 mm in
chronic dissections. The mean procedure time was very
similar for the both groups being 138 mins and 133.5 mins
for AAD and CAD respectively.
The proximal landing zones for the endovascular repair
were classified according to the position with respect to the
great vessels. The total cases covering the left common
carotid ostium were 3 in AAD and 9 in CAD, covering the
LSCA ostium (AAD 17, CAD15) and beyond the LSCA (AAD18,
CAD15). The planned site of the proximal endograft
necessitated a prior procedure in 4 cases for the acute
dissections and 11 cases in the chronic dissections. These
were 10 carotid-carotid-L subclavian bypasses and 5
carotid-L subclavian bypasses.Mortality, stroke and paraplegia
There was one 30-d death in the acute group (2.6%) due to
ongoing haemorrhage from a ruptured dissection. There
were three 30-d deaths in the chronic group (7.5%); two
from rupture of the aneurysmal false lumen in the abdomen
following an apparently successful procedure (after
hospital discharge) and one from a retrograde Type A
dissection. The 30-d stroke and paraplegia rates were
5.3% and 0% in AAD. There were no cases of stroke or
paraplegia in patients with CAD. Mean ICU stay was 3.7 days
and 2.7 days, while hospital stay was 18.7 days and 11.9
days (PZ 0.02) for AAD and CAD respectively.
Cumulative survival rates for patients with AAD and CAD
are illustrated in Fig. 1. At 30 months, the cumulative
survival for the two groups was 93% for AAD and 66.5% for
CAD. Patients with AAD had significantly higher survival
rates than patients with chronic disease (PZ 0.015, Kaplan
F
a
l
s
e
 
l
u
m
e
n
 
t
h
r
o
m
b
o
s
i
s
 
(
%
)
Time (months)
AAD
CAD
0
0
20
40
60
80
6 12 18 24 30 36
003671140CAD
12344628AAD
363024181260Time
a
b
Aortic Morphology Following Endovascular Repair of Acute and Chronic Type B Aortic Dissection 525Meier). This may be in part due to a higher prevalence of
renal disease, hypertension and hyperlipidaemia in the
patients with chronic dissections.
Secondary intervention
In patients treated for acute dissection, 8 required
a secondary procedure for continuing problems with the
thoracic aorta or endograft. There were 3 proximal proce-
dures for continuing proximal perfusion due to type 1
endoleak, 2 subclavian artery embolisations for Type II
endoleaks and three distal stent extensions for ongoing
false lumen perfusion in the thorax associated with aortic
expansion. None of these secondary procedures were
required in patients with IMH or penetrating aortic ulcers.
This cohort also required 6 procedures to treat other aortic
pathologies, which included 5 procedures on abdominal
aortic aneurysms (all in patients with classic dissection
except for one with IMH, one requiring a retrograde visceral
bypass and thoracoabdominal stenting), and one thora-
cotomy for a large haemothorax.
In the chronic cohort, 6 patients required secondary
procedures related to the dissection (one patient had
a subclavian embolisation for a Type II endoleak, one
required proximal stenting following a carotid-carotid
bypass for a proximal endoleak, one had a distal extension
due to persistent chest pain, one had a retrograde visceral
bypass and thoracoabdominal stenting, one had a sternot-
omy, ascending aortic bypass to the innominate and left
common carotid artery, followed by a proximal stent
extension for a persistently perfused false lumen of
a previous type A dissection and one patient required
treatment of a type A aneurysm). A further 8 had treatment
for other aortic pathology, which include 5 abdominal50
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Figure 1 Life table plotting cumulative survival (%) against
time (months), in patients having undergone endovascular
repair for acute (AAD) or chronic aortic dissection (CAD). The
numbers of patients at risk at each time point are given in
tabular form. The cumulative survival for patients with CAD
is significantly worse that for patients with AAD (PZ 0.015,
Kaplan Meyer).aneurysms and one ilio-femoral bypass. At 30 months the
cumulative freedom from re-intervention rate was 62% and
55% in CAD and AAD respectively (PZ 0.961, Kaplan-Meier).
False lumen thrombosis
The false lumen thrombosis rates were quantified at 7 aortic
levels and were also related to the position of the endograft.
When considering the false lumen thrombosis rates atF
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Figure 2 Life table plotting cumulative false lumen throm-
bosis rate at the mid point of the endovascular stent (%) (a)
and below the level of the endograft (b) against time (months),
in patients undergoing endovascular repair for acute (AAD) or
chronic aortic dissection (CAD). The numbers of patients at
risk at each time point are given in tabular form.
526 D. Sayer et al.different levels, the rates were lower the more distal the
measurement (data not shown). Fig. 2 illustrates the cumula-
tive false lumen thrombosis rates at the mid point of the
thoracic aortic endograft, and the thrombosis rate in the
thoracic aorta immediately below the endograft.
In general, the false lumen thrombosis rate at the level
of the endograft was similar for both acute and chronic
cases. Thrombosis rates for both AAD and CAD were lower in
the section of aorta immediately distal to the endograft
than at the mid-point of the endograft (PZ 0.005 AAD;
PZ 0.002 CAD). The false lumen thrombosis rate was
reduced for CAD in comparison to AAD when the thoracic
aorta below the level of the endograft was analysed. This
difference did not reach statistical significances (PZ 0.62).
Aortic dimensions following endovascular repair
The maximum short axis diameter of the thoracic aorta,
false lumen and true lumen diameters were measured at 745
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Figure 3 Bar graph plotting mean short axis diameter of the thora
raft (a) and below the level of the endograft (b) against time (mon
Post-immediately after repair). Values given are median with interq
for acute aortic dissection (AAD) and chronic aortic dissection (CApoints in the aorta and were also related to the level of
the endograft. These measurements are illustrated in
Fig. 3 for diameters at the mid point of the endograft
and immediately below the endograft in the thoracic
aorta. Diameter changes are illustrated for both AAD and
CAD. At the level of the endograft, endovascular repair
of AAD resulted in a significant increase in true lumen
diameter over time (PZ 0.001, ANOVA) and a significant
decrease in false lumen diameter (PZ 0.002, ANOVA).
The short axis diameter of the aorta in AAD was not signif-
icantly altered in AAD. These changes were similar,
although not as profound, in the aorta below the level
of the endograft.
In chronic dissections, endovascular repair did not
significantly alter the aortic dimensions either at the level
of the endograft or below this point. Again, this may reflect
the relative mobility of the dissection flap in acute and
chronic cases, but also suggests that different end points of
success might be defined for AAD and CAD.iameter At Stent
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Figure 3 Continued
Aortic Morphology Following Endovascular Repair of Acute and Chronic Type B Aortic Dissection 527The changes in the maximum short axis diameter of both
descending thoracic and abdominal aorta for both AAD and
CAD are illustrated in Fig. 4. Interestingly, following repair
of AAD, there are some apparent treatment failures with up
to 20% of patients experiencing expansion of the descend-
ing thoracic aorta, although this was defined by a 5 mm
increase in the present study. In spite of this, the abdom-
inal aorta remained relatively static. Conversely, following
repair of CAD, whilst a similar proportion of patients to
those with AAD experience dilatation of the thoracic aorta,
a much higher percentage appear to demonstrate dilatation
of the abdominal aorta.Discussion
Open surgery for aortic dissection has reported mortality
rates exceeding 30%,10e12 in comparison to the significantly
lower mortality rates for endovascular repair.4,13 The
present study supports the use of endovascular techniques
for AAD with an observed mortality rate of 2.6%, a stroke
rate of 5.3% and no cases of spinal cord ischaemia. All of
the acute cases in this investigation had robust indicationsfor treatment and 20 of the 38 necessitated coverage of the
left subclavian ostium.
Several previous reports have documented that
mortality following the treatment of acute dissections,
exceeds that for chronic cases.4,14 That was not observed in
the present study with a mortality rate for chronic dissec-
tions of 7.5%. This may partly reflect the increased
complexity of the chronic lesions that required a high prev-
alence of great vessel bypasses to create an adequate
landing zone; and required a greater number of stents.
All the deaths in this group may be attributed to the aortic
intervention, with one retrograde Type A dissection and
two patients with rupture of the false lumen in the
abdomen. The two patients with ruptured false lumens
provide a cause for concern. Previously our policy with
chronic dissecting aneurysms affecting the throacoabdomi-
nal aorta was to cover the primary entry tear, wait for
several months and only consider further intervention if
the false lumen was not thrombosing. Clearly this policy
needs to be considered following experience of false lumen
rupture. In patients with a significantly sized abdominal
component we would now advocate treatment of the entire
thoracoabdominal component at the same time; our
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Figure 4 Graph illustrating the percentage of patients having undergone endovascular repair of an acute aortic dissection (a) and
chronic aortic dissection (b) that demonstrated enlargement, reduction or stasis in the maximum short axis diameter of the
descending thoracic or abdominal aorta at varying time intervals after treatment. Enlargement and reduction were defined by
a change of more than 5 mm from the pre-treatment CT. Numbers of patients in each category are given.
528 D. Sayer et al.preference is to use retrograde visceral debranching and
endovascular repair. The case of retrograde Type A dissec-
tion followed treatment of a chronic dissecting aneurysm in
the mid descending thoracic aorta. Although a graft with
bare proximal attachment springs was placed, this was
not ballooned. Retrograde Type A dissection is now
accepted as a recognised complication of endovascular
thoracic procedures.15 However, the aetiology remains
largely undefined and further registry data are required
to determine robust associations with this complication
(current registry data collected at www.tevarcomplicat
ions.com).
Endovascular repair of thoracic dissections appears to
offer an attractive solution to the treatment of compli-
cated aortic dissections. However, although the early
outcomes with regard to operative mortality and morbidity
are promising, the longer-term outcomes remain under-
reported. Of significance in the present study was the high
rate of reintervention in both acute and chronic groups.
Interestingly, the majority of interventions were related to
synchronous problems with the abdominal aorta, which
highlights the importance of total aortic surveillance in
patients with aortic dissection. Additionally the difference
between mid-term survival was significant with the chronic
group faring poorly. The differences in survival may beattributable to a higher incidence of renal disease and
hypertension in the patients with CAD. The present sample
size is insufficient to perform a regression analysis to
determine whether survival is a function of the chronicity
of the dissection or other factors.
One of the primary aims in the endovascular treatment
of thoracic dissections is to achieve false lumen thrombosis
and/or aortic remodelling. In the present study, false
lumen thrombosis was similar in acute and chronic cases.
False lumen thrombosis was also greater at the level of the
endograft than distal to this. False lumen thrombosis rates
have not been extensively reported in the literature for
AAD and CAD separately. Kusagawa et al.7 observed that
false lumen thrombosis was complete in 76% of patients
with AAD after 2 years compared to just 36% of patients
with CAD. This rate appears inferior to that reported in
the present study, which may reflect differing definitions
and levels of analysis. In a cohort combining 129 acute
and chronic dissections, Resch et al.16 reported a false
lumen thrombosis rate at the level of the endograft of
80% with 50% of cases exhibiting distal perfusion, which
would be similar to the present study.
The most significant difference between the acute and
chronic cases in this study was related to the extent of
aortic remodelling. In the acute setting there was a rapid
Aortic Morphology Following Endovascular Repair of Acute and Chronic Type B Aortic Dissection 529expansion of the true lumen and collapse of the false lumen
around the stent within a year of the procedure. These are
similar findings to those reported by Schoder et al.17 In
chronic dissections the true and false lumen diameters do
not change to the same degree, which suggests that the
capacity for aortic remodelling in CAD is less. Distally, in
AAD, there appears to be some remodelling in the aorta
below the stent, but again, in CAD the changes in diameter
are minimal.
In acute dissections, up to 20% of the patients show
aortic dilatation in the thoracic segment 1 year after
endovascular repair, which appears to be similar to the
figure in chronic dissections observed in the present
study. Therefore, although the patients treated for AAD
appear to have a greater capacity for remodelling, the
chance of thoracic aortic dilatation with present treat-
ment algorithms remains. Late dilatation and aortic
rupture have previously been reported to a similar degree
in other studies.7,18 This possibility of enlargement
suggests that any technique which accelerates the true
and false lumen remodelling over the entire length of
the thoracic aorta may be beneficial. The concept of
a bare metal stent covering the thoracic aorta distal to
the covered entry site has been proposed,19 which has
the theoretical advantages of accelerating remodelling
but not raising the incidence of paraplegia from an
increased length aorta covered with a traditional
endograft.20
One further significant finding was the enlargement of
the abdominal aorta observed following endovascular
repair of both acute and chronic dissections. In AAD and
CAD, a substantial proportion of cases exhibited enlarge-
ment of the abdominal aorta and there were a number of
patients who required repair of an abdominal aortic
aneurysm. This finding emphasises the importance of long
term surveillance following endovascular treatment of
thoracic dissections and that the distal arterial tree should
be included in the imaging.
As with all new innovations, there are some unresolved
issues with endovascular repair of Type B thoracic dissec-
tions. One technical issue involves the length of thoracic
aorta that should be covered by the endograft in both AAD
and CAD. Current practice encompasses a spectrum of
opinion that ranges from those who believe that only the
entry tear should be covered, to those who believe that
the best results are obtained by covering the whole of the
thoracic aorta. The present study provides evidence to
support the assertion that different techniques should be
applied to the acute and chronic conditions. In patients
with AAD, the capacity for aortic remodelling appears to be
high and even the distal unstented aorta demonstrates
diameter changes with false lumen collapse and true lumen
expansion. This suggests that coverage of the primary entry
tear may be sufficient to treat AAD, as long as careful
surveillance of the thoracic and abdominal aorta is main-
tained. In contrast to the situation in AAD, patients with
chronic dissections demonstrate relatively little ability to
remodel the aorta, and therefore the integrity of the repair
is defined by achieving complete false lumen thrombosis. As
the false lumen thrombosis rates distal to the endograft are
particularly poor, a long length of aortic coverage is
required to achieve the best chance of success.References
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